Parallel Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$135K Buy
258
+7
+3% +$3.34K ﹤0.01% 1403
2025
Q4
$146K Sell
251
-8
-3% -$4.09K ﹤0.01% 1252
2025
Q3
$119K Sell
259
-13
-5% -$4.85K ﹤0.01% 1333
2025
Q2
$82.3K Sell
272
-12
-4% -$3.58K ﹤0.01% 1454
2025
Q1
$94.1K Buy
284
+85
+43% +$27.9K ﹤0.01% 1304
2024
Q4
$61.4K Buy
199
+111
+126% +$31.2K ﹤0.01% 1515
2024
Q3
$18.7K Hold
88
﹤0.01% 2137
2024
Q2
$24.7K Buy
88
+5
+6% +$1.19K ﹤0.01% 1864
2024
Q1
$22.2K Hold
83
﹤0.01% 1921
2023
Q4
$19.2K Buy
83
+78
+1,560% +$13.6K ﹤0.01% 1970
2023
Q3
$730 Hold
5
﹤0.01% 3032
2023
Q2
$1.16K Hold
5
﹤0.01% 2892
2023
Q1
$1.21K Hold
5
﹤0.01% 2912
2022
Q4
$1.45K Buy
+5
New +$489 ﹤0.01% 2798
2022
Q2
Sell
-3
Closed 3224
2022
Q1
$0 Buy
+3
New +$253 ﹤0.01% 3160
2021
Q3
Sell
-2
Closed 3193
2021
Q2
$0 Buy
+2
New +$237 ﹤0.01% 3013

Other funds holding MDGL